SOLVENTUM CORPORATION (SOLV) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 3.66B USD | Liabilities, Current |
| Cash and equivalents | 403.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.31B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 1.04B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.66B | $403.00M | (m) | $1.31B | $1.04B | (m) |
| 2026-03-31 | (m) | $3.35B | $561.00M | (m) | $1.06B | $1.09B | (m) |
| 2025-12-31 | (m) | $3.14B | $878.00M | (m) | $1.03B | $1.07B | (m) |
| 2025-09-30 | (m) | $2.94B | $1.64B | (m) | $1.02B | $1.05B | (m) |
| 2025-06-30 | (m) | $2.62B | $492.00M | (m) | $1.06B | $962.00M | (m) |
| 2025-03-31 | (m) | $2.57B | $534.00M | (m) | $926.00M | $866.00M | (m) |
| 2024-12-31 | (m) | $2.70B | $762.00M | (m) | $1.04B | $965.00M | (m) |
| 2024-09-30 | (m) | $2.90B | $772.00M | (m) | $1.10B | $953.00M | (m) |
| 2024-06-30 | (m) | $2.57B | $897.00M | (m) | $1.03B | $899.00M | (m) |
| 2024-03-31 | (m) | $1.85B | $996.00M | (m) | $1.22B | $901.00M | (m) |
| 2023-12-31 | (m) | $1.73B | $194.00M | (m) | $1.31B | $857.00M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |